HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)
-   -   Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-s (https://her2support.org/vbulletin/showthread.php?t=53068)

News 02-03-2012 06:00 AM

Pertuzumab plus trastuzumab and docetaxel has advantages over current clinical gold-s
 
Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.

More...


All times are GMT -7. The time now is 01:17 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021